KORU Medical Systems Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Raised Its FY24 Revenue Guidance Above Estimates. Also, Piper Sandler Maintained an Overweight Rating on the Stock and Raised Its...
KORU Medical Systems Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Raised Its FY24 Revenue Guidance Above Estimates. Also, Piper Sandler Maintained an Overweight Rating on the Stock and Raised Its...
koru medical systems股價上漲，公司公佈Q2業績超出預期並將FY24營業收入指引上調至高於預期。此外，派傑投資維持對該股票的超重評級並將...
KORU Medical Systems Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Raised Its FY24 Revenue Guidance Above Estimates. Also, Piper Sandler Maintained an Overweight Rating on the Stock and Raised Its Price Target From $2.5 to $3.
KORU Medical Systems公司發佈了超預期的Q2業績，並將FY24營收預期提高至預估以上，其股價因此上漲。此外，派傑投資將其股票評級保持爲 Overweight 並將價格目標從2.5美元上調至3美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。